Nonhematologic toxicities during course 1
. | . | Toxicity grade . | . | . | . | |||
---|---|---|---|---|---|---|---|---|
. | No. of patients . | 1 . | 2 . | 3 . | 4 . | |||
VPA dose, mg/kg | ||||||||
20 | 3 | 2 | 1 | 0 | 0 | |||
35 | 9 | 1 | 6 | 2 | 0 | |||
50 | 10 | 0 | 7 | 2 | 0 | |||
Phase 2, 50 mg/kg | 32 | 5 | 16 | 8 | 1 |
. | . | Toxicity grade . | . | . | . | |||
---|---|---|---|---|---|---|---|---|
. | No. of patients . | 1 . | 2 . | 3 . | 4 . | |||
VPA dose, mg/kg | ||||||||
20 | 3 | 2 | 1 | 0 | 0 | |||
35 | 9 | 1 | 6 | 2 | 0 | |||
50 | 10 | 0 | 7 | 2 | 0 | |||
Phase 2, 50 mg/kg | 32 | 5 | 16 | 8 | 1 |